je.st
news
Tag: enrollment
Costs Slow, Choices Abound In New Obamacare Open Enrollment
2014-11-09 20:20:59| Beverages - Topix.net
I've written about health care for more than two decades, starting from my native Iowa where I covered the presidential campaign bus rides of Bill and Hillary Clinton through the Hawkeye state talking health reform and the economy. I have covered the rise, fall and rise again of health reform, chronicling national trends as well as the influence of Barack and Michelle Obama from Chicago's South Side on changes to the U.S. health system from my base in Chicago.
Eleven Biotherapeutics Completes Enrollment In Pivotal Phase 3 Study Of EBI-005 in Patients With Dry Eye Disease
2014-11-05 05:46:07| drugdiscoveryonline Home Page
Eleven Biotherapeutics, a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, recently announced the completion of patient enrollment in its first pivotal, Phase 3 clinical study of EBI-005 in patients with dry eye disease
ComEd Launches Peak Time Savings; Open for Customer Enrollment
2014-10-23 18:18:00| Transmission & Distribution World
ComEd has launched its smart meter-enabled program called Peak Time Savings, which saves customers money by applying a credit to their bill for reducing electricity usage during high demand periods. read more
Tags: time
open
customer
savings
As Enrollment Decreases, Boyd Law School Plans to Increase Tuition
2014-09-17 02:04:18| Trucking - Topix.net
Summary: Although many law schools have cut tuition in hopes of increasing their enrollment, the University of Las Vegas William S. Boyd School of Law plans to hike tuition costs. The University of Las Vegas William S. Boyd School of Law is ranked as one of the top 100 law schools by U.S. News and World Report.
Tags: school
increase
law
plans
Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for...
2014-09-16 12:26:38| Chemicals - Topix.net
Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development. The study, called ARAMIS, evaluates ODM-201 in men with castration-resistant prostate cancer who have rising Prostate Specific Antigen levels and no detectable metastases.
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »